For the Inventor, By the Inventor

Enter assignee name

Boston, MA, United States of America

Centrexion Therapeutics Corporation

USPTO Granted Patents = 36

% Expired Patents = 8.3

EPO Patents = 11

Trademarks = 2

Forward Citations = 99

Loading Chart...

Loading Chart...

34 inventors (with patents filed for the assignee):

James N Campbell (11 out of 17 patents)

Henri Doods (9 out of 76 patents)

Riccardo Giovannini (9 out of 63 patents)

4. Rocco Mazzaferro (9 out of 16 patents)

5. Drazen Ostovic (6 out of 15 patents)

6. Gary Fred Musso (6 out of 24 patents)

7. Doris Riether (6 out of 49 patents)

8. Florian Paul Christian Binder (6 out of 18 patents)

9. Janet Rachel Nicholson (6 out of 13 patents)

10. Achim Sauer (6 out of 18 patents)

11. Marco Santagostino (5 out of 37 patents)

12. Kai Gerlach (5 out of 39 patents)

13. Stefan Scheuerer (5 out of 25 patents)

14. Thomas Trieselmann (5 out of 20 patents)

15. Sara Frattini (5 out of 34 patents)

Core Competencies:

Capsaicin

Pain Relief

CCR2 Antagonists

SSTR4 Agonists

Epidural Administration

Intrathecal Administration

High Concentration Anesthetics

Prodrug Compounds

Thiadiazoles

Isoxazoles

Local Anesthetics

36 patents: Sort by Forward Citations

1. 12344601 - (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles (2025-07-01),

2. 12268679 - Compositions and methods for epidural administration of MCOPPB for pain relief (2025-04-08),

3. 12209094 - CCR2 receptor antagonists and uses thereof (2025-01-28),

4. 12201594 - Methods and compositions for treatment of pain using capsaicin (2025-01-21),

5. 12076321 - (4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R,6S)-6-(p-tolyl)tetrahydro-2H-pyran-2-yl)methylamino)pyrimidin-4-yl)methanone citrate (2024-09-03),

6. 11992470 - Stable aqueous capsaicin injectable formulations and medical uses thereof (2024-05-28),

7. 11872219 - Compositions and methods for intrathecal administration of MCOPPB for pain relief (2024-01-16),

8. 11820727 - Capsaicinoid prodrug compounds and their use in treating medical conditions (2023-11-21),

9. 11731981 - CCR2 receptor antagonists and uses thereof (2023-08-22),

10. 11725004 - (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles (2023-08-15),

11. 11517546 - High concentration local anesthetic formulations (2022-12-06),

12. 11447444 - Capsaicinoid prodrug compounds and their use in treating medical conditions (2022-09-20),

13. 11344516 - Stable aqueous capsaicin injectable formulations and medical uses thereof (2022-05-31),

14. 11254659 - Capsaicinoid prodrug compounds and their use in treating medical conditions (2022-02-22),

15. 11147814 - (4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R,6S)-6-(p- tolyl)tetrahydro-2H-pyran-2-yl)methylamino)pyrimidin-4-yl)methanone citrate (2021-10-19),

Company Overview

Centrexion Therapeutics Corporation is a biopharmaceutical company based in Boston, MA, focused on developing innovative therapies for the treatment of pain. The organization specializes in advancing novel drug candidates that target specific pain pathways, aiming to provide effective solutions for patients suffering from chronic pain conditions. With a commitment to scientific research and development, Centrexion leverages its expertise in pharmacology and pain management to address unmet medical needs in the healthcare landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

36 Patents

#64 in Boston, MA

#561 in Massachusetts

#9,509 in US

#18,730 in the World

Boston, MA, United States of America

Centrexion Therapeutics Corporation

Forward Citations = 99

34 inventors:

James N Campbell (11 out of 17 patents)

Henri Doods (9 out of 76 patents)

Riccardo Giovannini (9 out of 63 patents)

4. Rocco Mazzaferro (9 out of 16 patents)

5. Drazen Ostovic (6 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Centrexion Therapeutics Corporation. Retrieved from https://idiyas.com/company/centrexion-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…